Tag: BioStable
ADVERTORIAL Early results for HAART 200 and HAART 300 Aortic Annuloplasty Devices are encouraging
The Duke Children’s Pediatric & Congenital Heart Center (Duke University Medical Center, Dur...
US FDA clears Biostable’s HAART 200 bicuspid aortic valve repair annuloplasty device
BioStable Science & Engineering has received US Food and Drug Administration (FDA) market cl...
BioStable Science & Engineering completes direct de novo application to FDA for an aortic annuloplasty device
BioStable Science & Engineering has completed a direct de novo application to the FDA for Cl...
